All posts tagged "239M"
-
86Health CareRecursion raises $239M in Series D, partners with lead investor Bayer
A startup developing artificial intelligence technology for drug discovery is partnering with a large German drugmaker in connection with its most recent...
-
73Health NewsRecursion Pharmaceuticals’ $239M for AI drug discovery, optimize.health’s $15.6M for remote patient monitoring and more digital health fundings
Artificial intelligence drug discovery company Recursion Pharmaceuticals has announced an oversubscribed Series D funding round totaling $239 million. Headlining the raise is...
